MTAP and melanoma: While physiological intracellular concentrations of MTA in the nM range might have a tumor-supporting role in MTAP deficient-melanoma cells [5], the administration of higher concentrations of MTA (μM) interfere with cell proliferation, lymphocyte activation, tumor development, invasiveness and the regulation of apoptosis [6-10].